1. Home
  2. AMAT vs VRTX Comparison

AMAT vs VRTX Comparison

Compare AMAT & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMAT
  • VRTX
  • Stock Information
  • Founded
  • AMAT 1967
  • VRTX 1989
  • Country
  • AMAT United States
  • VRTX United States
  • Employees
  • AMAT N/A
  • VRTX N/A
  • Industry
  • AMAT Semiconductors
  • VRTX EDP Services
  • Sector
  • AMAT Technology
  • VRTX Technology
  • Exchange
  • AMAT Nasdaq
  • VRTX Nasdaq
  • Market Cap
  • AMAT 126.7B
  • VRTX 115.6B
  • IPO Year
  • AMAT N/A
  • VRTX 1991
  • Fundamental
  • Price
  • AMAT $190.44
  • VRTX $459.81
  • Analyst Decision
  • AMAT Buy
  • VRTX Buy
  • Analyst Count
  • AMAT 24
  • VRTX 25
  • Target Price
  • AMAT $206.08
  • VRTX $509.00
  • AVG Volume (30 Days)
  • AMAT 7.2M
  • VRTX 1.2M
  • Earning Date
  • AMAT 08-14-2025
  • VRTX 08-04-2025
  • Dividend Yield
  • AMAT 0.97%
  • VRTX N/A
  • EPS Growth
  • AMAT N/A
  • VRTX N/A
  • EPS
  • AMAT 8.22
  • VRTX N/A
  • Revenue
  • AMAT $28,089,000,000.00
  • VRTX $11,099,700,000.00
  • Revenue This Year
  • AMAT $8.07
  • VRTX $10.43
  • Revenue Next Year
  • AMAT $5.76
  • VRTX $10.81
  • P/E Ratio
  • AMAT $23.17
  • VRTX N/A
  • Revenue Growth
  • AMAT 5.99
  • VRTX 8.98
  • 52 Week Low
  • AMAT $123.74
  • VRTX $377.85
  • 52 Week High
  • AMAT $224.09
  • VRTX $519.88
  • Technical
  • Relative Strength Index (RSI)
  • AMAT 58.33
  • VRTX 50.41
  • Support Level
  • AMAT $189.75
  • VRTX $463.40
  • Resistance Level
  • AMAT $201.11
  • VRTX $472.22
  • Average True Range (ATR)
  • AMAT 3.79
  • VRTX 9.33
  • MACD
  • AMAT -0.75
  • VRTX 0.12
  • Stochastic Oscillator
  • AMAT 47.20
  • VRTX 45.40

About AMAT Applied Materials Inc.

Applied Materials Inc is the largest semiconductor wafer fabrication equipment, or WFE, manufacturer in the world. Applied Materials has a broad portfolio spanning nearly every corner of the WFE ecosystem. Specifically, Applied Materials holds a market share leadership position in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: